 |
 |
|
|
RESÚMENES MARZO 2007 |
Psychotic Disorders
& Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia
After Discontinuing Perphenazine: A CATIE Study
T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, George A. Capuano, Robert A. Rosenheck, Richard S.E. Keefe, Alexander L. Miller, Irving Belz, John K. Hsiao, for the CATIE Investigators
Am J Psychiatry
164:415-427, March 2007
Effects of
Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE
Study
Marvin S. Swartz, Diana O. Perkins, T. Scott Stroup, Sonia M. Davis,
George Capuano, Robert A. Rosenheck, Fred Reimherr, Mark F. McGee, Richard S.E. Keefe, Joseph P. McEvoy, John K. Hsiao, Jeffrey A. Lieberman, for the CATIE
Investigators
Am J Psychiatry
164:428-436, March 2007
Which antipsychotics would mental health professionals take
themselves?
Stephen Bleakley, Olubanke Olofinjana, David
Taylor
Psychiatric
Bulletin (2007) 31: 94-96
Does
marijuana contribuye to psychotic illness? Cannabis abuse is not benign, especially in
adolescents
Ray JM
TEXTO
GRATUITO
Antipsychotics
equivalent? CUtLASS renews the debate. Is
Robert J. Constantine, Rajiv Tandon
TEXTO GRATUITO
Biological Markers
and the Future of Early Diagnosis and Treatment in Schizophrenia
Psychiatry Times. February 2007, Vol. XXIV, No. 2
TEXTO
GRATUITO
The Metabolic
Syndrome and Schizophrenia: Clinical Research Update
Psychiatry Times. February 2007, Vol. XXIV, No. 2
TEXTO
GRATUITO
Childhood-Onset
Schizophrenia: Diagnostic and Treatment Challenges
Psychiatry Times. February 2007, Vol. XXIV, No. 2
TEXTO
GRATUITO
Differential
Medication Adherence Among Patients With Schizophrenia
and Comorbid Diabetes and Hypertension
John D. Piette, Michele Heisler,
Dara Ganoczy, John F. McCarthy,
and Marcia Valenstein
Psychiatr
Serv 58:207-212, February 2007
Risk factors for
schizophrenia — All roads lead to dopamine
Marta Di Forti, Julia M. Lappin and Robin M. Murray
European
Neuropsychopharmacology. Volume 17, Supplement 2, March 2007, Pages S101-S107
Effects of acute
abstinence, reinstatement, and mecamylamine on biochemical and behavioral
measures of cigarette smoking in schizophrenia
Andrea H.
Weinberger, Kristi A. Sacco, Cerissa L. Creeden, Jennifer C. Vessicchio,
Peter I. Jatlow and Tony P. George
Schizophrenia Research. Volume 91, Issues 1-3, March 2007, Pages 217-225
Fertility of first-degree relatives of
patients with schizophrenia: A three generation perspective
Anna C. Svensson, Paul Lichtenstein, Sven Sandin
and Christina M. Hultman
Schizophrenia Research. Volume 91, Issues 1-3, March 2007, Pages 238-245
Risk of death
associated with the use of conventional versus atypical antipsychotic drugs
among elderly patients
Sebastian Schneeweiss, Soko
Setoguchi, Alan Brookhart,
Colin Dormuth and Philip S. Wang
CMAJ.
February 27, 2007; 176 (5)
TEXTO GRATUITO
Comparative
Effectiveness of Off-Label Use of Atypical Antipsychotics
Shekelle P, Maglione
M, Bagley S, Suttorp M, Mojica
WA, Carter J, Rolon C, Hilton L, Zhou A, Chen S,
Glassman P
Comparative Effectiveness Review No. 6. Agency for Healthcare Research and Quality. January 2007
TEXTO GRATUITO
A review of aripiprazole in
the treatment of patients with schizophrenia or bipolar I disorder
Neuropsychiatric Disease and Treatment 2006; Volume: 2 | Issue: 4: 427-443
Atypical antipsychotics
and polydipsia: a cause or a treatment?
Giuseppe Bersani,
Lorenzo Pesaresi, Valerio Orlandi, Simona Gherardelli, Paolo Pancheri
Human
Psychopharmacology: Clinical and Experimental. Volume 22,
Issue 2, Pages 103 - 107
Brain Volumes in Relatives of Patients With Schizophrenia. A
Meta-analysis
Heleen B.
M. Boos, André Aleman, Wiepke Cahn, Hilleke Hulshoff Pol, René S. Kahn
Arch Gen Psychiatry. 2007;64:297-304
Analysis of
clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration
in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial
Rael D. Strous, Rafael Stryjer, Rachel Maayan, Gilad Gal, Dina Viglin, Elena Katz, Dana Eisner and Abraham Weizman
Psychoneuroendocrinology. Volume 32, Issue 2, February 2007, Pages 96-105
The atypical antipsychotic, aripiprazole,
blocks phencyclidine-induced disruption of prepulse
inhibition in mice
Kim Fejgin, Sergej Safonov, Erik Pålsson,
Caroline Wass, Jörgen A. Engel,
Lennart Svensson and
Daniel Klamer
Psychopharmacology. Volume 191, Number 2 / April, 2007:377-385
Quality Of Life In Schizophrenia On Conventional Versus Atypical
Antipsychotic Medication: A Comparative Cross-Sectional Study
Ann M. Mortimer, Ahemed Omar Ahmed Al-Agib
International
Journal of Social Psychiatry, Vol. 53, No. 2, 99-107 (2007)
Cannabinoids
and Psychosis
Deepak Cyril D'Souza
International
Review of Neurobiology. Volume 78, 2007, Pages 289-326
Paliperidone:
quo vadis?
L.
Citrome
International Journal of Clinical Practice (OnlineEarly Articles).
Danijela Piskulic, James S. Olver, Trevor
R. Norman and Paul Maruff
Psychiatry Research. Volume 150, Issue 2, 30 March 2007, Pages
111-121
Characteristics of smokers
with a psychotic disorder and implications for smoking interventions
Psychiatry Research. Volume 150, Issue 2, 30 March 2007, Pages
141-152
Birth order and the
severity of illness in schizophrenia
Fiona Gaughran,
Robert Blizard, Ramya
Mohan,
Psychiatry Research. Volume
150, Issue 2, 30 March 2007, Pages 205-210
J
Clin Psychiatry 2007;68:361-367
Jean-Pierre Lindenmayer, Anzalee Khan, Adel Iskander, Maria T. Abad, and Benedicto
Parker
J
Clin Psychiatry 2007;68:368-379
J
Clin Psychiatry 2007;68:399-405
Ronald D. Spurling, J. Steven Lamberti,
David Olsen, Xin Tu, and
Wan Tang
J
Clin Psychiatry 2007;68:406-409
Treatment of Tardive Dyskinesia With Galantamine: A Randomized
Controlled Crossover Trial
J
Clin Psychiatry 2007;68:410-415
André Aleman,
Iris E. Sommer, and René S. Kahn
J
Clin Psychiatry 2007;68:416-421
Early
Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia
Stefan Leucht, Raymonde Busch, Werner Kissling, and John M. Kane
J
Clin Psychiatry 2007;68:352-360
Benzodiazepines
and schizophrenia, a review of the literature
R. Gaillard, Ouanas, Spadone, Llorca, Lôo, Baylé
L’Encephale. Vol 32 -
N° 6 - Décembre 2006:1003 - 1010
Quality of
life and subjective well-being during treatment with antipsychotics
in out-patients with schizophrenia
Atypical Antipsychotics versus Haloperidol for Treatment of Delirium
in Acutely Ill Patients
Pharmacotherapy 2007. Volume: 27 | Issue: 4: 588-594 Managing the acute psychotic episode Peter Byrne BMJ 2007;334:686-692 (31 March) TEXTO GRATUITO